James R Tobin insider trades: Globus Medical (GMED) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where James reports to the SEC
and 3 more companies
Open-market buys and sales
18 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Sep 15, 2026 | GMED | ↓ Sell | 30,000 | $74.58 | $2.2M | Direct | Sep 16, 2026 (1d) |
| Aug 8, 2024 | TMDX | ↓ Sell | 20,000 | $159.33 | $3.2M | By the James R. Tobin 2012 Trust | Aug 9, 2024 (1d) |
| May 3, 2024 | TMDX | ↓ Sell | 12,025 | $125.05 | $1.5M | By the James R. Tobin 2012 Trust | May 7, 2024 (4d) |
| May 1, 2024 | TMDX | ↓ Sell | 15,040 | $106.43 | $1.6M | By the James R. Tobin 2012 Trust | May 3, 2024 (2d) |
| Mar 1, 2024 | TMDX | ↓ Sell | 13,380 | $83.63 | $1.1M | By the James R. Tobin 2012 Trust | Mar 5, 2024 (4d) |
| Nov 28, 2023 | TMDX | ↓ Sell | 10,000 | $70.14 | $701K | By the James R. Tobin 2012 Trust | Nov 29, 2023 (1d) |
| Feb 23, 2023 | TMDX | ↓ Sell | 10,000 | $75.13 | $751K | By the James R. Tobin 2012 Trust | Feb 27, 2023 (4d) |
| Jul 29, 2022 | TMDX | ↓ Sell | 48,515 | $39.98 | $1.9M | By the James R. Tobin 2012 Trust | Aug 1, 2022 (3d) |
| Jul 5, 2022 | TMDX | ↓ Sell | 48,515 | $35.00 | $1.7M | By the James R. Tobin 2012 Trust | Jul 6, 2022 (1d) |
| May 4, 2022 | TMDX | ↓ Sell | 48,516 | $29.94 | $1.5M | By the James R. Tobin 2012 Trust | May 6, 2022 (2d) |
| Mar 15, 2022 | GMED | ↓ Sell | 8,850 | $65.47 | $579K | Direct | Mar 17, 2022 (2d) |
| Mar 10, 2022 | GMED | ↓ Sell | 14,484 | $70.65 | $1.0M | Direct | Mar 10, 2022 (0d) |
| May 10, 2021 | GMED | ↓ Sell | 25,000 | $71.96 | $1.8M | Direct | May 12, 2021 (2d) |
| Feb 9, 2021 | TMDX | ↓ Sell | 10,168 | $32.83 | $334K | By the James R. Tobin 2012 Trust | Feb 10, 2021 (1d) |
| Sep 2, 2020 | GMED | ↓ Sell | 5,600 | $56.85 | $318K | Direct | Sep 3, 2020 (1d) |
| Aug 25, 2020 | GMED | ↓ Sell | 17,400 | $54.40 | $947K | Direct | Aug 26, 2020 (1d) |
| Feb 28, 2019 | GMED | ↓ Sell | 37,000 | $47.59 | $1.8M | Direct | Feb 28, 2019 (0d) |
| Mar 30, 2011 | CRIS | ↓ Sell | 11,987 | $3.27 | $39K | Direct | Apr 1, 2011 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other GMED insiders
Open-market trades in the last 12 months
About James R Tobin's insider trades
James R Tobin is an insider at Globus Medical (GMED). Since Mar 30, 2011, James has reported no open-market purchases and 18 sales worth $23.0M on SEC Form 4. In the last 12 months: 1 sale ($2.2M).
Their filings also include grants and awards (71 filings), option exercises (12 filings), gifts (3 filings), shares returned to the company (3 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every GMED insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.